SANRI BENZERİ SAPLANTILAR İLE SOMATİK SEMPTOMLARIN EŞLİK ETTİĞİ OBSESİF KOMPULSİF SEMPTOMLARIN AYIRICI TANISI, BİR OLGU SUNUMU
Obsesif Kompulsif Semptomlar, özellikle de zorlayıcı nedensiz obsesyonlarını açıklamada güçlük çeken çocuk ve ergenlerde olmak üzere sanrılar ile karışabilmektedir. Obsesyonlar, aşırı zihinsel uğraşlar ve sanrılar ile karışabilmektedir. Psikosomatik semptomlar çocuklar tarafından sıklıkla belirtilen bir durumdur ve sürekli baş ağrıları anksiyete bozukluğu olan kişilerde nadir değildir. Sürekli baş ağrıları terapotik yaklaşımı olumsuz olarak etkileyebilmektedir ve aynı zamanda doğru tedaviye de ulaşmayı güç- leştirmektedir. Bu olguda obsesif kompulsif semptoloji ile başvuran bir kız ergendeki tanısal güçlükleri ile bu semptomların psikoeğitim ve farmakoterapi ile başarılı bir şekilde tedavisi tartışılmaktadır. Aynı zamanda obsesif kompulsif bozukluğun (OCD) doğ- ru tanısı ile ergenler ile ailelerine psikoeğitim verilmesinin bu gençlerin öz güvenlerine kavuşmaları ve aileleri ile tekrar yapılandırılmış bir ilişki kurmaları için önemi tartışılacaktır. Bu yaş bireylerde OKB’nin farmakolojik tedavisinde seçilecek ajan Selektif Serotonin Geri Alım İnhibitöreleridir (SSRI). Son olarak bu olgunun anksiyete ile ilişkili bir durum olarak doğru şekilde tanımlanması ve psikolojik yaklaşımı ile farmakolojik yönetimi oldukça önemlidir
CASE REPORT: DIFFERENTIAL DIAGNOSIS OF OBSESSIVE-COMPULSIVE SYMPTOMS CONFOUNDED BY DELUSION-LIKE FIXATIONS AND SOMATIC SYMPTOMS IN AN ADOLESCENT
Obsessive-compulsive symptoms can at times be confounded by delusional symptoms, which can be especially challenging to interpret correctly in children and adolescents, who may struggle to articulate the intrusive or unreasonable nature of their obsessions. Obsessions, overvalued ideas and delusions can have an overlap. Persistent headaches are not uncommon amongst patients presenting with anxiety disorders and psychosomatic symptoms are frequently reported by children. Psychosomatic complaints, such as enduring headaches, can also have an undesirable impact on therapeutic approach and delay access to the correct treatment. In this case we discuss diagnostic pitfalls in an adolescent girl presenting with obsessive-compulsive symptomatology and a successful treatment of enduring symptoms with psycho-education and medication. We will argue that psycho-education for young people and their families based on a correct diagnosis of obsessive compulsive disorder (OCD) is essential to provide reassurance, to help young people regain self-confidence and re-establish constructive relationships within the family unit. Selective serotonin re-uptake inhibitors (SSRI) are the drug of choice for pharmacological treatment of OCD in this age group. We conclude that a correct diagnosis of the condition as "anxiety-driven" was of paramount importance for psychological approach and pharmacological management of this case.
___
- American Psychiatric Association: Diagnostic and Statistical
Manual of Mental Disorders, Fourth ed. rev. Washington DC,
American Psychiatric Association, 2000.
- Rasmussen SA, Eisen JL. Epidemiology of obsessive
compulsive disorder. Journal of Clinical Psychiatry. 1990;53:10–
14.
- Piacentini J, Bergman RL, Keller M, McCracken J. Functional
impairment in children and adolescents with obsessivecompulsive
disorder. Journal of Child and Adolescent
Psychopharmacology. 2003;13:61–69.
- Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology
of obsessive-compulsive disorder in the National Comorbidity
Survey Replication. Molecular Psychiatry. 2010;15:53–63.
- Zohar AH. The epidemiology of obsessive-compulsive
disorder in children and adolescents. Child AdolescPsychiatrClin
N Am. 1999;8:445-460.
- Thomsen PH. Obsessivecompulsive disorder: Pharmacological
treatment. Eur Child Adolsc Psychiatry 2000;9 Suppl 1:/I/7684.
- The Pediatric OCD Treatment Team. Cognitivebehaviour
therapy, sertraline, and their combination for children and
adolescents with obsessivecompulsive disorder: The Pediatric
OCD Treatment Study (POTS) randomized controlled trial.
JAMA. 2004;292:1969-76.
- March JS, Frances A, Carpenter D, Kahn DA. The expert
consensus guidelines series: Treatment of obsessivecompulsive
disorder. J Clin Psychiatry. 1997;58:172.
- Aardema F, O’Connor KP, Emmelkamp PM, Marchand A,
Todorov C. Behavinferencial confusion in obsessive-compulsive
disorder: the inferencial confusion questionnaire. Res Ther.
2005;43(3):293-308.
- Kitis A, Akdede BB, Alptekin K, Akvardar Y, Arkar H, Erol A, et al.
Cognitive dysfunctions in patients with obsessive-compulsive
disorder compared to the patients with schizophrenia patients:
relation to overvalued ideas. ProgNeuropsychopharmacolBiol
Psychiatry. 2007;31(1):254-61.
- Rapaport JL, Inoff G. Practitioner review: Treatment of
obsessive-compulsive disorder in children and adolescents. J.
Child PsycholPsychiat. 2000;41:419-431.
- Singer, H. S. (2015). PANDAS: The need to use definitive
diagnostic criteria.Tremor and Other Hyperkinetic Movements
2015;5:327.
- O’Dwyer AM, Marks I. Obsessive-compulsive disorder and
delusions revisited. Br J Psychiatry. 2000;176:281-4.
- Ercan E. S, Ardic UA, Ercan E, Yuce D, Durak S. A Promising
Preliminary Study of Aripiprazole for Treatment-Resistant
Childhood Obsessive-Compulsive Disorder. Journal of child and
adolescent psychopharmacology. 2015;25(7):580-584.
- McKenna PJ. Disorders with overvalued ideas. British Journal
of Psychiatry. 1984;145:579 -585.
- Hudson JI, Mangweth B, Pope HG Jr, Hausmann A, De
Col C, Laird NM, Beibl W, Tsuang MT. Family study of affective
spectrum disorder. Arch Gen Psychiatry 2003;60:170-177
- Dinn WM, Aycicegi-Dinn A, Robbins NC, Harris CL. Migraine
Headache and Obsessive-Compulsive Symptoms in a Student
Sample. Bulletin of Clinical Psychopharmacology. 2005; 15:174-
181
- Scarella TM, Laferton JA, Ahern DK, Fallon BA, Barsky A. The
Relationship of Hypochondriasis to Anxiety, Depressive, and
Somatoform Disorders. Psychosomatics. 2016;57(2):200-207.
19. Hocaoğlu Ç. Farklı Bir Hipokondriyazis: Bir Vaka Sunumu.
Journal of Mood Disorders. 2015;5(1):36-9.